Salman Mustfa
Senior Scientist AstraZeneca
Seminars
Tuesday 27th January 2026
Engineering Next-Generation Cas9s to Advance Rare Disease Therapy Portfolio
11:30 am
- Explore how engineered Cas9 variants are expanding precision, efficiency, and safety in gene editing applications
- Review strategies for tailoring Cas9 platforms to address the unique challenges of rare disease indications
- Learn from case studies on building a diversified rare disease pipeline through Cas9- based therapeutic development
